Tricyclic antidepressants, first developed in the 1950s, are no longer in wide use. But the results of a recent study by a research team at Stanford University (Stanford, CA, USA) could well give them a new lease of life—not for depression, but for small-cell lung cancer. The team have discovered that the tricyclic antidepressant imipramine can curb the growth of human small-cell lung cancers in mice and tumour cell cultures. The drug killed nearly 100% of the tumour cells in culture. The Lancet Respiratory Medicine~
Posted on: Tue, 04 Nov 2014 13:07:44 +0000
Trending Topics
Recently Viewed Topics
© 2015